author-photo

Ester Pungolino

University of Parma

89

Papers

2606

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (2)
Nilotinib induced Bone Marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: final report of the PhilosoPhi34 study.

2021 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Increased tumor burden in Chronic Myeloid Leukemia patients after 36 months of imatinib discontinuation.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study.

2020 Blood Research
Show All
- Source
- Cite
- Save
Citations (1)
IDENTIFICATION OF MIRNA AND TARGET GENES IN THE TRANSCRIPTOME ANALYSIS OF CD34+/LIN- CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AFTER 12 MONTHS OF NILOTINIB THERAPY

2019
Show All
- Source
- Cite
- Save
Citations (0)
Progressive Down Regulation of JAK-STAT, Cell Cycle, and ABC Transporter Genes in CD34+/Lin- Cells of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients at Diagnosis Vs. 12 Months of Nilotinib Treatment Vs. Healthy Subjects

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (5)
Jak-2 and Nfkbia Gene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia

2018 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (3)